CLINICAL_TRIALS
research
· 2017-10-23
Clinical Trial Update: Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial [Phase 4]
Summary
Phase 4 randomized trial investigating whether stopping magnesium sulfate after delivery is safe and effective for women with severe preeclampsia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cairo University | Conditions: Preeclampsia Severe | Phase 4 | Status: UNKNOWN